Back
12
Also listed as
ACOPY
OTC
Day Range
$6.59
$6.86
52-Week Range
$4.27
$6.86
Volume
146
50D / 200D Avg
$6.13
/
$5.69
Prev Close
$6.59
Price History
Financial Trends
Peer Comparison
vs Consumer Defensive sector median (329 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 23.6 | 10.4 |
| P/B | 3.3 | 1.2 |
| ROE % | 14.9 | 12.3 |
| Net Margin % | 10.7 | 5.3 |
| Rev Growth 5Y % | 12.1 | 5.6 |
| D/E | 0.1 | 0.6 |
Key Takeaways
Revenue grew 12.05% annually over 5 years — strong growth
Earnings grew 21.07% over the past year
ROE of 14.93% — decent returns on equity
Debt/Equity of 0.07 — conservative balance sheet
Generating 197.51M in free cash flow
Cash machine — converts 97.35% of earnings into free cash flow
Growth
Revenue Growth (5Y)
12.05%
Revenue (1Y)13.50%
Earnings (1Y)21.07%
FCF Growth (3Y)39.69%
Quality
Return on Equity
14.93%
ROIC10.59%
Net Margin10.68%
Op. Margin11.53%
Safety
Debt / Equity
0.07
Current Ratio3.22
Interest Coverage88.50
Valuation
P/E Ratio
23.56
P/B Ratio3.29
EV/EBITDA17.26
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13.50% | Revenue Growth (3Y) | 9.26% |
| Earnings Growth (1Y) | 21.07% | Earnings Growth (3Y) | 14.18% |
| Revenue Growth (5Y) | 12.05% | Earnings Growth (5Y) | 25.94% |
| Profitability | |||
| Revenue (TTM) | 1.90B | Net Income (TTM) | 202.89M |
| ROE | 14.93% | ROA | 10.45% |
| Gross Margin | 46.08% | Operating Margin | 11.53% |
| Net Margin | 10.68% | Free Cash Flow (TTM) | 197.51M |
| ROIC | 10.59% | FCF Growth (3Y) | 39.69% |
| Safety | |||
| Debt / Equity | 0.07 | Current Ratio | 3.22 |
| Interest Coverage | 88.50 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 23.56 | P/B Ratio | 3.29 |
| P/S Ratio | 2.52 | PEG Ratio | 1.37 |
| EV/EBITDA | 17.26 | Dividend Yield | 0.01% |
| Market Cap | 4.78B | Enterprise Value | 3.78B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.90B | 1.67B | 1.59B | 1.44B | 1.21B |
| Net Income | 202.89M | 167.58M | 155.64M | 122.62M | 80.66M |
| EPS (Diluted) | 0.28 | 0.23 | 0.21 | 0.16 | 0.11 |
| Gross Profit | 875.16M | 766.63M | 739.16M | 663.52M | 509.71M |
| Operating Income | 219.04M | 202.24M | 201.22M | 177.41M | 126.42M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.94B | 1.73B | 1.61B | 1.72B | 1.37B |
| Total Liabilities | 511.37M | 478.10M | 462.21M | 521.89M | 288.05M |
| Shareholders' Equity | 1.45B | 1.27B | 1.15B | 1.18B | 1.08B |
| Total Debt | 100.74M | 66.22M | 101.53M | 124.35M | 16.50M |
| Cash & Equivalents | 1.10B | 968.94M | 352.23M | 437.31M | 875.15M |
| Current Assets | 1.45B | 1.29B | 1.12B | 1.17B | 1.10B |
| Current Liabilities | 450.08M | 416.77M | 379.21M | 440.17M | 274.69M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#1009 of 1024
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026